The National Pharmaceutical Pricing Authority (NPPA) has revised the ceiling prices of BCG Vaccine, Measles Rubella Vaccine, and Measles Vaccine following a review by the Department of Pharmaceuticals. The revised prices include the applicable Wholesale Price Index adjustment and aim to ensure continued availability of these important vaccines while addressing concerns related to pricing methodology and market viability.
The National Pharmaceutical Pricing Authority (NPPA) has issued a notification revising the ceiling prices of BCG Vaccine, Measles Rubella Vaccine, and Measles Vaccine under the Drugs (Prices Control) Order, 2013. The revision follows a review order issued by the Department of Pharmaceuticals after concerns were raised regarding the application of monopoly price reduction methodology to these vaccines.
Under the revised notification, the ceiling prices have been updated to Rs. 9.89 per dose for BCG Vaccine, Rs. 87.93 per vial for Measles Rubella Vaccine, and Rs. 62.00 per vial for Measles Vaccine, including the Wholesale Price Index (WPI) adjustment of 0.64956%.
Key requirements include:
- Compliance with the revised ceiling prices by all manufacturers.
- Submission of updated price lists to NPPA and relevant authorities.
- Quarterly reporting of production, import, and sales data.
- Prior approval for new drug launches under DPCO provisions.
The revision aims to support vaccine availability, maintain market viability, and ensure continued public access to essential immunization products.